https://www.selleckchem.com/pr....oducts/Cyclopamine.h
GEM was minimally effective in suppressing GEM cell activity, but the therapeutic effectiveness of Evr against pancreatic cancer growth was greater in GEM cells than that in GEM cells. In vivo studies confirmed that while GEM failed to inhibit the progression of GEM tumors, Evr significantly decreased the volume of GEM tumors while suppressing tumor cell proliferation and enhancing tumor apoptosis in the presence of GEM. Evr treatment may be a promising strategy to target the growth and activity of GEM-resistant pancreatic cancer ce
Aimer
Commentaire
Partagez
